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Abstract: A library of bidentate diols, as well as tridentate triols and aminodiols, derived from
(+)-sabinol, was synthesized in a stereoselective manner. Sabinol was transformed into allylic
trichloroacetamide via Overman rearrangement of the corresponding trichloroacetimidate. After
changing the protecting group to Boc, the enamine was subjected to stereospecific dihydroxylation
with OsO4/NMO, resulting in the (1R,2R,3R,5R)-aminodiol diastereomer. The obtained primary
aminodiol was transformed to a secondary analogue. The ring closure of the N-benzyl-substituted
aminodiol with formaldehyde was investigated and regioselective formation of the spiro-oxazolidine
ring was observed. Hydroboration or dihydroxylation of sabinol or its benzyl ether with OsO4/NMO
resulted in the formation of sabinane-based diols and triols following a highly stereospecific reaction.
Treatment of sabinol with m-CPBA afforded O-benzoyl triol as a diastereoisomer of the directly
dihydroxylated product, instead of the expected epoxy alcohol. The resulting aminodiols, diol, and
triols were applied as chiral catalysts in the reaction of diethylzinc and benzaldehyde from moderate
to good selectivity.
Keywords: sabinol; terpenoid; catalyst; chiral ligand; triol; aminodiol; asymmetric catalysis
1. Introduction
In recent years, the discovery and application of new chiral auxiliaries and catalysts have
become a crucial question in stereoselective syntheses [1–4]. To achieve new, efficient, and
commercially available chiral catalysts, natural chiral terpenes [5], including (+)-pulegone [6–8],
α- and β-pinene [9–14], and fenchone-camphor [15–19] have proved to be excellent sources. Starting
from these readily available natural sources, several powerful chiral catalysts, including various di- and
trifunctional synthons, such as 1,3-aminoalcohols and aminodiols, have been applied in stereoselective
syntheses [5,20].
Besides their importance in enantioselective catalysis, 3-amino-1,2-diols are good starting materials
for the synthesis of various heterocyclic ring systems, such as 1,3-oxazines or oxazolidines [8,11,21–25].
Several mono- or bicyclic aminodiol derivatives possess remarkable biological activity. The Abbott
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aminodiol was also found to be a useful building block for the synthesis of the potent renin inhibitor
Zankiren [26]. Some 3-amino-1,2-diols have been investigated as selective antagonists on receptor
P2X1 [27]. Cytoxazone is a naturally occurring heterocyclic aminodiol derivative isolated from
Streptomyces species [28,29], and expresses cytokine modulator activity by inhibiting the signaling
pathway of Th2 cells [30,31]. Some bicyclic aminodiol-based carbocyclic nucleoside analogues exert
antiviral activity [32].
Monoterpene-based diols or triols have also proved to be easily available, good chiral auxiliaries
and catalysts [33,34]. Some of the terpenoid diols also possess marked biological, e.g., antimicrobial,
antifungal or enzyme inhibitor activities [35–37].
Similar to pinane- and carane-based allylic alcohols, (+)-sabinol and its acetate are available
from the essential oil of several plants e.g., Juniperus sabina L. in a large scale [38–40]. Although this
interesting monoterpene derivative has been intensively studied from the biological point of view,
it was scarcely investigated for its chemical transformations [41].
Our present aim was to synthesize a library of sabinane-based chiral di- and trifunctional synthons,
such as 3-amino-1,2-diols, diols, and triols starting from (+)-sabinol, achieved from a natural source.
We also decided to evaluate the resulting synthons as catalysts in the asymmetric addition of Et2Zn to
benzaldehyde. The planned aminodiols, diols, and triols may serve as useful building blocks for the
synthesis of new heterocyclic ring systems and biologically active compounds.
2. Results
2.1. Synthesis and Transformations of Sabinol-Based 3-Amino-1,2-Diols
(+)-Sabinol 1, the key starting material, was isolated from the essential oil of Juniperus sabina L.
according to the literature procedure, and its purity was found to be >98% based on GC analysis [38–40].
Sabinol was transformed into trichloroacetimidate 2 in the presence of trichloroacetonitrile and
DBU as a strong base (Scheme 1) [8,11]. 2 underwent Overman rearrangement by heating in the
presence of K2CO3, resulting in protected allylamine 3 [42]. Since we have found difficulties during the
deprotection of N-trichloroacetyl aminodiols in our recent studies [8], we have changed the protecting
group to Boc in a two-step process via enamine 4. Stereospecific dihydroxylation of 5, applying OsO4
as the catalyst and NMO as the oxidant, produced protected (1R,2R,3R,5R)-aminodiol 6 as a single
diastereomer (based on the 1H NMR study of the crude product). Acid-catalyzed removal of the
protecting group resulted in primary aminodiol hydrochloride 7 with 41% overall yield.
Scheme 1. Reagents and conditions: (i) CCl3CN, DBU, dry CH2Cl2, rt, 2 h; (ii) anhydrous K2CO3,
dry xylene, reflux, 12 h, 77%; (iii) 2 N aq NaOH, EtOH, rt, 2 h, 72%; (iv) Boc2O, TEA, DMAP, THF, rt,
22 h, 95%; (v) OsO4, NMO, acetone/H2O, rt, 12 h, 93%; (vi) 5% aq HCl, Et2O, rt, 24 h, 77%; (vii) 15% aq
KOH, CH2Cl2, rt, 83%.
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The relative configuration of 6 was determined by NOESY spectral analysis. Clear NOE correlations
were observed between Me of the isopropyl group at position 5 and H-1, OH-2, as well as between
H-6 and H-3, CH2NHBoc. Therefore, the structure of 6 was assigned as shown in Figure 1.
Figure 1. Determination of the relative configuration of 6 by NOESY.
Aminodiol 8 was transformed to N-benzyl derivative 9 by reductive alkylation via condensation
with benzaldehyde, followed by subsequent reduction with sodium borohydride (Scheme 2). Next,
the regioselectivity of the ring closure of 9 with formaldehyde was investigated. The reaction has proved
to be highly regioselective, resulting only in spiro-oxazolidine 10, while the fused 1,3-oxazine structure
could not be detected from the crude product by means of 1H NMR spectroscopy. This observation shows
similarity with earlier results we have obtained after ring closure of pinane-based 3-amino-1,2-diols [23],
and it is in contrast with those of carane-based analogues [24,25].
Scheme 2. Reagents and conditions: (i) PhCHO, dry EtOH, 2 h, then NaBH4, EtOH, 48 h, rt, 56%; (ii) 35%
aq CH2O, Et2O, rt, 1 h, 90%.
2.2. Synthesis and Transformations of Sabinol-Based Diols and Triols
Since monoterpenic diols and triols might serve as chiral catalysts or could be used as excellent
starting materials for the synthesis of more complex 1,3-heterocycles [34,43], we decided to explore the
preparation and some transformations of sabinane-based diols and triols starting from (+)-sabinol 1.
Hydroboration reaction of 1 with BH3·THF or BH3·Me2S followed by treatment with H2O2
resulted in cis bicyclic diol 11 in a highly stereospecific reaction (Scheme 3). Beside the NOESY spectral
structural analysis, the relative configuration of 11 was determined by X-ray crystallography (Figure 2).
Scheme 3. (i) BH3·THF, THF, 0 ◦C to rt, 2.5 h, then NaOH/H2O2/H2O, THF, rt, 30 min, 47%;
(ii) BH3·Me2S, THF, 0 ◦C to rt, 18 h, then NaOH/H2O2/H2O, THF, rt, 30 min, 70%.
The planes of the two rings in 11 make an angle of 76.90(14)◦. The cyclopentane ring has an
envelope conformation with atom C1 as the tip. The substituent O6–H6 occupies an axial position on
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the envelope tip, whereas the isopropyl and O8–H8 substituents are in equatorial positions. In the
crystal packing, both hydroxyl groups are involved in hydrogen bonds [O6 . . . O8(−1/2 + x,−1/2 − y,
1 − z) = 2.6796(18) Å, O8 . . . O6(1 + x, y, z) = 2.7223(16) Å], resulting in a double chain of molecules
running in the a-axis direction (Figure S1).
Figure 2. Crystal structure of compound 11. Thermal ellipsoids are drawn at the 50% probability level.
The synthesis of sabinane-based triols also started from 1. (+)-Sabinol was treated with the OsO4/NMO
system providing triol 13 in a highly stereospecific reaction. In order to compare the catalytic
importance of hydroxyl functions, O-benzyl derivative 14 was also prepared via benzylation of 1
with benzyl bromide, followed by stereospecific dihydroxylation (Scheme 4).
Scheme 4. (i) BnBr, NaH, THF, reflux, 1 h, 92%; (ii) OsO4, NMO, acetone/H2O, rt, 12 h, 44%; (ii) OsO4,
NMO, acetone/H2O, rt, 12 h, 81%.
Treatment of sabinol 1 with m-CPBA did not yield the desired epoxide 15. Rather, the generated
epoxide underwent an in situ ring-opening process after the electrophilic attack of the formed
m-chlorobenzoic acid, resulting in ester 17 (Scheme 5) [44–46]. The intermediate epoxide could
not be isolated even after applying miscellaneous conditions, such as varying temperature, NaHCO3
or Na2CO3, or buffer solutions. 17 easily underwent acyl migration under the applied conditions,
affording its structural isomer 18. Interesting to note that while under slightly alkaline work up
conditions (sat. NaHCO3 solution) only isomer 18 was isolated, applying strong alkaline conditions
(10% NaOH solution), the mixture of two regioisomers was isolated. Acyl migration of the pure
products could also be observed during 13C NMR analysis in CDCl3 solution. It must be mentioned
that Garside et al. reported a similar reaction of sabinol with peracetic acid; however, they observed
ring rearrangement and formation of acetyl p-menthane-1,2,4-triol [47].
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Scheme 5. (i) m-CPBA, CH2Cl2, Na2HPO4 buffer sol., (pH = 9.2), rt, 1 h, work up with 10% NaOH/H2O,
37% (mixture of 17 and 18); (ii) m-CPBA, CH2Cl2, Na2HPO4. buffer sol. (pH = 9.2), rt, 1 h, work up
with sat. NaHCO3/H2O, 38% (18); (iii) 10% NaOH/H2O, EtOH, rt, 30 min, 91%.
The regioisomeric relation of 17 and 18 was determined by their hydrolysis under alkaline
conditions, which furnished stereohomogenic compound 19, whereas the relative configuration of
19 was assigned by NOESY spectral structural analysis and 19 was found to be a diastereoisomer of
triol 13.
2.3. Application of Sabinol-Based Aminodiol, Diol and Triol Derivatives as Chiral Ligands in the
Enantioselective Addition of Diethylzinc to Benzaldehyde
Application of the prepared 3-amino-1,2-diols (8–10), 1,3-diol (11), and triols (13,14 and 17–19)
as catalysts in the ethylation of benzaldehyde resulted in 1-phenyl-1-propanol enantiomers 21 and
22 (Scheme 6).
Scheme 6. Catalyzed addition of diethylzinc to benzaldehyde.
The enantiomeric purity of the secondary alcohol obtained was determined by HPLC analysis [7].
Catalysts were applied in 10% molar ratio and reactions were carried out in n-hexane at room
temperature. The results are presented in Table 1.
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Table 1. Addition of diethylzinc to benzaldehyde, catalyzed by various types of diol, triols, and
aminodiols at room temperature.
Entry Catalyst (10 mol %) Yield 1 (%) ee 2 (%) Config. of Major Product 3
1 8 88 44 S
2 9 98 66 S
3 10 98 58 S
4 11 73 6 S
5 13 88 12 S
6 14 87 17 S
7 17 73 9 S
8 18 95 4 S
9 19 81 8 S
1 Yields after silica column chromatography. 2 Determined on the crude product by HPLC (Chiracel OD–H).
3 Determined by comparing the tR of the HPLC analysis and the optical rotation with the literature data [7].
In the addition of Et2Zn in n-hexane solution to benzaldehyde, diol 11, or triols 13, 14, and 17–19
afforded the corresponding alcohols with low enantioselectivities. The stereoselectivity could not be
improved either by changing the solvent to toluene or lowering the reaction temperature. Increased,
but still moderate asymmetric induction was observed when aminodiol derivatives 8–10 were used.
The formation of S enantiomer 22 was predominant in all cases.
3. Experimental Section
3.1. Materials and Methods
1H and 13C NMR spectra were recorded on a Bruker Avance DRX 300 and 500 spectrometer
[δ = 0 (TMS)] (Bruker Corp., Billerica, MA, USA) in the solvents indicated. Chemical shifts are
expressed in ppm (δ) relative to TMS as internal reference. J values are given in Hz. Elemental analyses
were performed on a Perkin-Elmer 2400 Elemental Analyzer (PerkinElmer Inc., Waltham, MA, USA).
Chiral HPLC analysis was performed without derivatization by JASCO LC-4000 system on a Chiralcel
OD-H column (250 × 4.6 mm, Jasco Europe S.R.L., Cremella, Italy). UV detection was monitored
at 215 nm. Optical rotations were obtained with a Perkin-Elmer 341 polarimeter (PerkinElmer
Inc., Shelton, CT, USA). Melting points were determined on a Kofler apparatus (Nagema, Dresden,
Germany) and are uncorrected. Chromatographic separations were carried out on Merck Kieselgel
60 (230–400 mesh ASTM, Merck Ltd., Budapest, Hungary). Reactions were monitored with Merck
Kieselgel 60 F254-precoated TLC plates (0.25 mm thickness). All chemicals and solvents were used
as supplied.
Sabinol 1 was isolated from the essential oil of Juniperus sabina L. according to a literature
process [38–40].
Synthesis of 2,2,2-trichloro-N-(((1R,5S)-5-isopropylbicyclo[3.1.0]hex-2-en-2-yl)methyl)acetamide (3). To a
solution of sabinol 1 (4.00 g, 26.27 mmoL) in dry CH2Cl2 (50 mL) 1,8-diazabicycloundec-7-ene (2 mL,
13.39 mmoL) and CCl3CN (4.68 mL, 46.67 mmoL) were added at 0 ◦C. The reaction mixture was
then allowed to warm to room temperature and stirred for 2 h. When the reaction was completed
(monitored by means of TLC), the mixture was concentrated to a volume of 20 mL and then filtered
through a short pad of silica gel, washing with CH2Cl2. Evaporation of the solvent in vacuum gave
a brown oil, which was immediately dissolved in dry xylene (200 mL). To this solution, anhydrous
K2CO3 (1.00 g, 7.23 mmoL) was added, and the mixture was treated at reflux temperature overnight.
The obtained solution was then filtered through a Celite pad, washed, and concentrated under reduced
pressure. The obtained crude product was purified by column chromatography on silica gel (Rf = 0.52;
n-hexane/EtOAc = 9/1).
Compound 3: 6.03 g (77%); pale-yellow crystalline powder; mp: 45–47 ◦C; [α]20D = +7 (c = 0.250;
MeOH). 1H NMR (300 MHz, CDCl3) δ (ppm): 0.08 (1H, t, J = 3.4 Hz), 0.84 (1H, dd, J = 3.8, 7.5 Hz), 0.90
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(3H, d, J = 6.9 Hz), 0.95 (3H, d, J = 6.8 Hz), 1.39–1.52 (2H, m), 2.25 (1H, d, J = 17.7 Hz), 2.45 (1H, dd,
J = 2.2, 17.7 Hz), 3.98–4.16 (2H, m), 5.26 (1H, s), 6.79 (1H, br s). 13C NMR (75 MHz, CDCl3) δ (ppm):
19.9, 20.2, 21.8, 28.4, 32.8, 34.0, 36.4, 41.8, 92.9, 124.0, 144.1, 161.8. Anal. Calcd for C12H16Cl3NO: C
48.59; H 5.44; Cl 35.86; N 4.72. Found: C 48.65; H 5.52; Cl 35.63; N 4.68.
Synthesis of ((1R,5S)-5-isopropylbicyclo[3.1.0]hex-2-en-2-yl)methanamine (4). A solution of acetamide 3
(5.95 g, 20 mmoL) in ethanol (30 mL) was stirred with 2 N aqueous NaOH solution (30 mL) at room
temperature for 2 h. The reaction mixture was then concentrated to an aqueous residue which was
extracted with CH2Cl2 (3 × 30 mL). The organic layer was dried (Na2SO4) and evaporated to dryness.
Compound 4 was used without further purification.
Compound 4: 2.18 g (72%); yellow oil; [α]20D = −5 (c = 0.250; MeOH). 1H NMR (500 MHz, CDCl3)
δ (ppm): 0.05 (1H, t, J = 3.2 Hz), 0.80 (1H, dd, J = 3.5, 7.5 Hz), 0.90 (3H, d, J = 6.8 Hz), 0.95 (3H, d,
J = 6.8 Hz), 1.41–1.47 (4H, m), 2.22 (1H, d, J = 17.3 Hz), 2.41 (1H, dd, J = 2.0, 17.3 Hz), 3.37 (2H, dd,
J = 15.4, 15.6 Hz), 5.13 (1H, s). 13C NMR (125.8 MHz, CDCl3) δ (ppm): 19.8, 20.1, 21.7, 28.7, 32.8, 33.7,
36.4, 42.7, 120.0, 151.2. Anal. Calcd for C10H17N: C 79.41; H 11.33; N 9.26. Found: C 79.63; H 11.45;
N 9.01.
Synthesis of tert-butyl (((1R,5S)-5-isopropylbicyclo[3.1.0]hex-2-en-2-yl)methyl)carbamate (5). To a solution
of 4 (2.00 g, 13.22 mmoL) TEA (3.34 g, 33.05 mmoL), DMAP (0.16 g, 1.32 mmoL) in THF (100 mL)
and Boc2O (3.17 g, 14.54 mmoL) were added at room temperature. The reaction mixture was stirred
for 22 h and then concentrated under reduced pressure. The crude product was purified by column
chromatography on silica gel (Rf = 0.50; n-hexane/EtOAc = 9/1).
Compound 5: 3.16 g (95%); pale-yellow oil; [α]20D = +6 (c = 0.250; MeOH).
1H NMR (500 MHz,
CDCl3) δ (ppm): 0.04 (1H, t, J = 3.1 Hz), 0.80 (1H, dd, J = 3.7, 7.5 Hz), 0.89 (3H, d, J = 6.8 Hz), 0.94 (3H,
d, J = 6.7 Hz), 1.44–1.47 (2H, m), 1.45 (9H, s), 2.21 (1H, d, J = 17.5 Hz), 2.40 (1H, dd, J = 2.0, 17.4 Hz),
3.81 (2H, s), 4.59 (1H, br s), 5.15 (1H, s). 13C NMR (125.8 MHz, CDCl3) δ (ppm): 19.8, 20.1, 21.6, 28.4,
28.4, 32.7, 33.7, 36.3, 41.1, 79.2, 122.1, 146.3, 155.9. Anal. Calcd for C15H25NO2: C 71.67; H 10.02; N 5.57.
Found: C 71.88; H 10.20; N 5.41.
Synthesis of tert-butyl (((1R,2R,3R,5R)-2,3-dihydroxy-5-isopropylbicyclo[3.1.0]hexan-2-yl)methyl)carbamate
(6). To 5 (3.00 g, 11.93 mmoL) in acetone (50 mL) 4-methylmorpholine N-oxide (10 mL, 50% aqueous
solution) and OsO4 (4 mL, 2% tert-BuOH solution) were added. The reaction mixture was stirred
for 12 h at room temperature. The reaction was then quenched by the addition of saturated aqueous
Na2SO3 (50 mL) and extracted with EtOAc (3 × 50 mL). The combined organic phase was dried
(Na2SO4) and evaporated, then the crude residue was purified by column chromatography (Rf = 0.43;
n-hexane/EtOAc = 1:1).
Compound 6: 3.16 g (93%); off-white crystalline powder; mp: 68–70 ◦C; [α]20D = +38 (c = 0.250;
MeOH). 1H NMR (500 MHz, CDCl3) δ (ppm): 0.30 (1H, dd, J = 3.9, 5.4 Hz), 0.38–0.44 (1H, m), 0.88 (3H,
d, J = 6.9 Hz), 0.97 (3H, d, J = 6.8 Hz), 1.19 (1H, dd, J = 3.6, 8.5 Hz), 1.34 (1H, quint, J = 6.8 Hz), 1.45 (9H,
s), 1.66 (1H, dd, J = 9.6, 11.5 Hz), 2.05 (1H, dd, J = 7.3, 12.2 Hz), 3.22 (1H, dd, J = 6.8, 14.2 Hz), 3.30 (1H,
dd, J = 5.2, 14.3 Hz), 3.58 (1H, t, J = 8.1 Hz), 5.03 (1H, br s). 13C NMR (125.8 MHz, CDCl3) δ (ppm): 13.3,
19.7, 19.8, 28.4, 28.9, 31.3, 32.6, 34.4, 47.0, 73.3, 79.1, 80.0. Anal. calcd for C15H27NO4: C 63.13; H 9.54;
N 4.91. Found: C 63.29; H 9.65; N 4.73.
Synthesis of (1R,2R,3R,5R)-2-aminomethyl-5-isopropylbicyclo[3.1.0]hexane-2,3-diol hydrochloride (7).
A solution of 6 (1.20 g, 4.20 mmoL) in Et2O (30 mL) was stirred with 30 mL of 5% aqueous HCl
at room temperature. After 24 h, the two phases were separated, the aqueous phase was washed
with Et2O (3 × 30 mL) and then evaporated to dryness. Crystals formed were thoroughly washed
with Et2O.
Compound 7: 0.72 g (77%); colorless crystals; mp: 146–148 ◦C; [α]20D = +42 (c = 0.250; MeOH). 1H
NMR (500 MHz, D2O) δ (ppm): 0.41 (1H, dd, J = 3.9, 5.6 Hz), 0.54–0.59 (1H, m), 0.85 (3H, d, J = 6.9 Hz),
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0.97 (3H, d, J = 6.8 Hz), 1.30 (1H, dd, J = 3.6, 8.5 Hz), 1.47 (1H, septet, J = 6.8 Hz), 1.75 (1H, dd, J = 10.0,
11.71 Hz), 2.15 (1H, dd, J = 7.4, 12.3 Hz), 3.10 (2H, s), 3.66 (1H, dd, J = 7.9, 8.7 Hz). 13C NMR (125.8
MHz, D2O) δ (ppm): 11.8, 18.6, 19.1, 26.7, 31.6, 32.0, 33.2, 45.0, 72.8, 77.0. Anal. calcd for C10H20ClNO2:
C 54.17; H 9.09; N 6.32. Found: C 54.28; H 9.29; N 6.01.
Synthesis of (1R,2R,3R,5R)-2-((benzylamino)methyl)-5-isopropylbicyclo[3.1.0]hexane-2,3-diol (9). To a solution of
aminodiol 8 liberated from 7 (0.37 g, 2 mmoL) in dry ethanol (20 mL) benzaldehyde (0.32 g, 3 mmoL)
was added in one portion, and the solution was stirred at room temperature for 1 h and then evaporated
to dryness. The residual product was dissolved again in dry ethanol (20 mL) and stirred for a further
1 h. Next NaBH4 (0.23 g, 6 mmoL) was added in small portions to the mixture under ice cooling. After
stirring for 48 h, the mixture was evaporated to dryness and the residue was dissolved in H2O and
extracted with CH2Cl2 (3 × 30 mL). The combined organic layer was dried (Na2SO4), filtered and
evaporated to dryness. The obtained crude product was purified by column chromatography on silica
gel (Rf = 0.21; toluene/ethanol = 4/1).
Compound 9: 0.31 g (56%); colorless crystals; mp: 111–113 ◦C; [α]20D = +41 (c = 0.250; MeOH).
1H NMR (500 MHz, CDCl3) δ (ppm): 0.22 (1H, dd, J = 4.0, 5.3 Hz), 0.32–0.36 (1H, m), 0.87 (3H, d,
J = 6.9 Hz), 0.97 (3H, d, J = 6.8 Hz), 1.14 (1H, dd, J = 3.7, 8.5 Hz), 1.32 (1H, septet, J = 6.8 Hz), 1.63 (1H,
dd, J = 9.8, 11.5 Hz), 2.02 (1H, dd, J = 7.3, 12.3 Hz), 2.62 (1H, d, J = 11.9 Hz), 2.91 (1H, d, J = 11.9 Hz),
3.52 (1H, t, J = 7.8 Hz), 3.79 (1H, d, J = 13.2 Hz), 3.85 (1H, d, J = 13.2 Hz), 7.26–7.36 (5H, m). 13C NMR
(125.8 MHz, CDCl3) δ (ppm): 13.1, 19.6, 19.7, 29.5, 31.7, 32.8, 34.1, 54.2, 55.0, 75.0, 77.6, 127.2, 128.2,
128.5, 139.7. Anal. calcd for C17H25NO2: C 74.14; H 9.15; N 5.09. Found: C 74.25; H 9.10; N 5.15.
Synthesis of (1R,2R,3R,5R)-3′-benzyl-5-isopropylspiro[bicyclo[3.1.0]hexane-2,5′-oxazolidin]-3-ol (10). To the
solution of 9 (0.15 g, 0.54 mmoL) in Et2O (5 mL) 35% aqueous formaldehyde solution (2 mL) was
added. The reaction mixture was stirred for 1 h at room temperature, followed by making it alkaline
with 10% cold aqueous KOH solution and extracted with Et2O (3 × 20 mL). The organic layers were
combined, washed with saturated NaCl solution (3 × 20 mL) then dried (Na2SO4), filtered, and
evaporated to dryness. The crude product was purified by column chromatography on silica gel
(Rf = 0.64; toluene/ethanol = 4/1).
Compound 10: 0.14 g (90%); pale-yellow oil; [α]20D = +63 (c = 0.250; MeOH).
1H NMR (500 MHz,
(CD3)2SO) δ (ppm): 0.27–0.32 (2H, m), 0.84 (3H, d, J = 6.8 Hz), 0.93 (3H, d, J = 6.8 Hz), 1.17–1.21 (1H, m),
1.24–1.32 (1H, m), 1.56 (1H, dd, J = 10.1, 11.2 Hz), 1.78 (1H, dd, J = 7.1, 11.7 Hz), 2.68 (1H, d, J = 11.0 Hz),
2.93 (1H, d, J = 11.0 Hz), 3.41 (1H, dd, J = 9.4, 16.8 Hz), 3.75 (2H, s), 4.13 (1H, d, J = 4.5 Hz), 4.25 (1H,
d, J = 9.5 Hz), 4.41 (1H, d, J = 4.4 Hz), 7.22–7.37 (5H, m). 13C NMR (125.8 MHz, (CD3)2SO) δ (ppm):
13.5, 20.2, 20.2, 30.5, 31.9, 32.9, 34.2, 57.9, 58.0, 74.2, 86.7, 87.3, 127.4, 128.7, 129.0, 139.8. Anal. calcd for
C18H25NO2: C 75.22; H 8.77; N 4.87. Found: C 75.31; H 8.91; N 4.70.
Synthesis of (1R,3S,4S,5S)-4-hydroxymethyl-1-isopropylbicyclo[3.1.0]hexan-3-ol (11). Method A: to a cooled
(0 ◦C) solution of sabinol 1 (0.15 g, 1 mmoL) in 3 mL dry THF under nitrogen atmosphere, a solution
of 1 M borane THF complex (2 mL) was injected dropwise. After completing the addition, the mixture
was allowed to warm to room temperature and stirred for 2.5 h. After completion of hydroboration 0.5
mL of cold water was added and the mixture was stirred for 10 min. This was followed by adding 0.3
mL of 3 N aqueous solution of NaOH and then 0.3 mL of 35% H2O2. The mixture was stirred for an
additional 30 min, then quenched by the addition of 5 mL ice-cold water and extracted with EtOAc (3
× 10 mL). The organic phases were collected, washed with brine, dried over Na2SO4 and evaporated.
The residue was subjected to chromatography on silica gel (Rf = 0.21; n-hexane/EtOAc = 3/2).
Method B: to a cooled (0 ◦C) solution of sabinol 1 (0.15 g, 1 mmoL) in 5 mL dry THF under argon
atmosphere 0.21 mL of 95% solution of borane dimethyl sulfide complex (BMS) in DMS was injected,
then the reaction mixture was allowed to warm up to room temperature and stirred for 18 h. The work
up of the reaction mixture was the same as for Method A.
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Compound 11: Method A: 0.08 g, (47%); Method B: 0.12 g (70%); colorless crystals; mp: 66–68 ◦C;
[α]20D = +35 (c = 0.250; MeOH).
1H NMR (500 MHz, CDCl3) δ (ppm): 0.31–0.35 (1H, m), 0.85–0.89 (4H,
m), 0.93 (3H, d, J = 6.8 Hz), 0.95–0.99 (1H, m), 1.37 (1H, septet, J = 6.8 Hz), 1.75 (1H, d, J = 14.1 Hz), 2.08
(1H, ddd, J = 1.4, 6.8, 14.2 Hz), 2.10 (1H, s), 2.46–2.53 (1H, m), 3.83 (1H, dd, J = 9.0, 10.6 Hz), 3.90 (1H,
dd, J = 5.5, 10.7 Hz), 4.41 (1H, t, J = 6.5 Hz). 13C NMR (125.8 MHz, CDCl3) δ (ppm): 13.9, 19.8, 19.9, 24.2,
32.7, 33.0, 38.5, 47.7, 62.5, 73.3. Anal. calcd for C10H18O2: C 70.55; H 10.66. Found: C 70.48; H 10.79.
Synthesis of (1R,3S,5R)-3-benzyloxy-1-isopropyl-4-methylenebicyclo[3.1.0]hexane (12). To a stirred
suspension of NaH (6 mmoL) in dry, freshly distilled THF (10 mL), a THF solution (3 mL) of 1
(0.30 g, 2 mmoL) was added at room temperature under argon atmosphere. After 30 min stirring,
a solution of benzyl bromide (0.34 g, 2 mmoL) in THF (3 mL) was added dropwise at room temperature,
and the reaction mixture was kept at boiling temperature for 1 h. The reaction was quenched by the
addition of H2O (2 mL), and then THF was removed under reduced pressure to about 10% of the initial
volume. After adding ice-cold water (25 mL) to the obtained residue, the aqueous phase was extracted
with CH2Cl2 (4 × 20 mL), then the organic phase was dried (Na2SO4), filtered and evaporated to
dryness. The crude residue was purified by flash column chromatography on silica gel (Rf = 0.80;
n-hexane/EtOAc = 19:1).
Compound 12: 0.45 g (92%); pale-yellow oil; [α]20D = +7 (c = 0.250; MeOH).
1H NMR (500 MHz,
CDCl3) δ (ppm): 0.69–0.73 (1H, m), 0.87 (3H, d, J = 6.9 Hz), 0.93 (3H, d, J = 6.8 Hz), 1.18–1.21 (1H, m),
1.46 (1H, septet, J = 6.8 Hz), 1.64 (1H, dd, J = 2.4, 8.5 Hz), 1.89 (1H, d, J = 13.9 Hz), 2.05 (1H, ddd, J = 1.4,
7.3, 13.8 Hz), 4.08 (1H, d, J = 7.2 Hz), 4.32 (1H, d, J = 11.8 Hz), 4.57 (1H, d, J = 11.7 Hz), 4.88 (1H, s), 5.11
(1H, s), 7.27–7.39 (5H, m). 13C NMR (125.8 MHz, CDCl3) δ (ppm): 18.6, 19.7, 19.8, 29.1, 32.6, 35.7, 36.7,
69.8, 81.3, 108.4, 127.3, 127.7, 128.3, 138.7, 152.3. Anal. calcd for C17H22O: C 84.25; H 9.15. Found: C
84.43; H 9.33.
3.2. General Procedure for the Preparation of 13 and 14
To a solution of 1 or 12 (0.66 mmoL) in acetone (5 mL) 4-methylmorpholine N-oxide (0.33 mL, 50%
aqueous solution) and OsO4 (0.25 mL, 2% tert-BuOH solution) were added, and the reaction mixture
was stirred for 24 h at room temperature. Then, the reaction was quenched by the addition of saturated
aqueous Na2SO3 (5 mL) and extracted with EtOAc (3 × 10 mL). The organic layer was dried (Na2SO4)
and evaporated. The purification of the crude product was accomplished by column chromatography
on silica gel (13: Rf = 0.15, 14: Rf = 0.40; n-hexane/EtOAc = 3/2).
(1R,2R,3S,5R)-2-Hydroxymethyl-5-isopropylbicyclo[3.1.0]hexane-2,3-diol (13): 0.10 g (81%); white crystalline
powder; mp: 148–150 ◦C; [α]20D = +4 (c = 0.250; MeOH). 1H NMR (500 MHz, (CD3)2SO) δ (ppm):
0.18–0.24 (1H, m), 0.82 (3H, d, J = 6.8 Hz), 0.84 (1H, t, J = 4.1 Hz), 0.90 (3H, d, J = 6.8 Hz), 0.96–1.01 (1H,
m), 1.34 (1H, septet, J = 6.8 Hz), 1.46 (1H, d, J = 13.2 Hz), 2.09 (1H, ddd, J = 1.0, 6.6, 13.0 Hz), 3.42 (1H,
dd, J = 6.3, 11.0 Hz), 3.55 (1H, dd, J = 5.4, 11.0 Hz), 3.69–3.73 (1H, m), 4.08 (1H, t, J = 5.8 Hz), 4.12 (1H, s),
4.42 (1H, d, J = 4.1 Hz). 13C NMR (125.8 MHz, (CD3)2SO) δ (ppm): 12.5, 19.8, 20.0, 30.0, 31.8, 32.3, 36.1,
63.8, 76.9, 83.4. Anal. calcd for C10H18O3: C 64.49; H 9.74. Found: C 64.60; H 9.88.
(1R,2R,3S,5R)-3-Benzyloxy-2-hydroxymethyl-5-isopropylbicyclo[3.1.0]hexan-2-ol (14): 0.08 g (44%); colorless
semi-solid; [α]20D = +4 (c = 0.250; MeOH).
1H NMR (500 MHz, CDCl3) δ (ppm): 0.41–0.46 (1H, m), 0.90
(3H, d, J = 6.9 Hz), 0.94–0.97 (1H, m), 0.98 (3H, d, J = 6.8 Hz), 1.04–1.08 (1H, m), 1.44 (1H, septet, J = 6.8
Hz), 1.88 (1H, d, J = 13.9 Hz), 2.11 (1H, ddd, J = 1.6, 6.6, 13.9 Hz), 3.66 (1H, d, J = 11.4 Hz), 3.73 (1H, d,
J = 6.5 Hz), 3.94 (1H, d, J = 11.4 Hz), 4.27 (1H, d, J = 11.8 Hz), 4.57 (1H, d, J = 11.8 Hz), 7.26–7.37 (5H,
m). 13C NMR (125.8 MHz, CDCl3) δ (ppm): 13.2, 19.9, 20.1, 29.3, 31.7, 32.2, 33.3, 65.2, 71.4, 85.1, 85.8,
127.5, 127.7, 128.5, 138.2. Anal. calcd for C17H24O3: C 73.88; H 8.75. Found: C 73.99; H 8.84.
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3.3. General Procedure for the Preparation of 17 and 18
Method A: to a mixture of 1 (1.00 g, 6.57 mmoL) dissolved in 50 mL CH2Cl2 and Na2HPO4·12H2O
(3.40 g, 9.49 mmoL) dissolved in 100 mL water (pH = 9.2), m-chloroperbenzoic acid (75% purity,
7.47 mmoL) was added in one portion at 0 ◦C, and the mixture was stirred at room temperature.
When the reaction was complete, as indicated by TLC (1 h), the mixture was separated, and the aqueous
phase was extracted with CH2Cl2 (100 mL). The organic layer was washed with 10% NaOH solution
(3 × 50 mL), dried (Na2SO4), and evaporated. The residue was purified by column chromatography
on silica gel to afford a mixture of 17 and 18 (0.78 g, 37%, 17:18 = 2:1). Product 17 (0.30 g) was isolated
in pure form by recrystallization from CH2Cl2/n-hexane.
Method B: to a solution of 1 (0.50 g, 3.28 mmoL) in 25 mL CH2Cl2 and Na2HPO4·12H2O (1.70 g,
4.74 mmoL) in 50 mL water (pH = 9.2), a solution of m-chloroperbenzoic acid (75% purity, 3.74 mmoL)
in CH2Cl2 (25 mL) was added dropwise over 10 min at 0 ◦C, and the mixture was stirred at room
temperature. When the reaction was complete, as indicated by TLC (1 h), the mixture was separated,
and the aqueous phase was extracted with CH2Cl2 (50 mL). The organic layer was washed with
saturated aqueous solution of NaHCO3 (3 × 50 mL), dried (Na2SO4), and evaporated to afford 18 as
the single product.
((1R,2S,3S,5R)-2,3-dihydroxy-5-isopropylbicyclo[3.1.0]hexan-2-yl)methyl 3-chlorobenzoate (17). Method A,
0.30 g (14%, in isolated pure form); white crystals; mp: 93–96 ◦C; [α]20D = +22 (c = 0.250; MeOH). 1H
NMR (500 MHz, CDCl3) δ (ppm): 0.48–0.52 (1H, m), 0.87 (3H, d, J = 6.9 Hz), 0.92 (3H, d, J = 6.8 Hz),
1.16 (1H, t, J = 4.2 Hz), 1.30–1.37 (2H, m), 1.89 (1H, d, J = 14.3 Hz), 2.10 (1H, ddd, J = 1.1, 7.0, 14.2 Hz),
2.54 (1H, br s), 2.81 (1H, br s), 3.95 (1H, d, J = 7.0 Hz), 4.30 (1H, d, J = 11.6 Hz), 4.39 (1H, d, J = 11.6
Hz), 7.40 (1H, t, J = 7.9 Hz), 7.55 (1H, d, J = 8.0 Hz), 7.96 (1H, d, J = 7.9 Hz), 8.04 (1H, s). 13C NMR
(125.8 MHz, CDCl3) δ (ppm): 13.7, 19.5, 19.7, 29.5, 32.4, 32.8, 35.2, 69.4, 72.9, 80.7, 127.9, 129.8, 129.8,
131.5, 133.3, 134.7, 165.6. Anal. calcd for C17H21ClO4: C 62.86; H 6.52. Found: C 63.01; H 6.60.
(1R,3S,4S,5R)-4-Hydroxy-4-hydroxymethyl-1-isopropylbicyclo[3.1.0]hexan-3-yl 3-chlorobenzoate (18). Method
B, 0.40 g (38%); white crystalline powder; mp: 110–112 ◦C; [α]20D = +12 (c = 0.250; MeOH). 1H NMR
(400 MHz, CDCl3) δ (ppm): 0.55–0.61 (1H, m), 0.91 (3H, d, J = 6.9 Hz), 0.95 (3H, d, J = 6.8 Hz), 1.23
(1H, t, J = 4.4 Hz), 1.38 (1H, septet, J = 6.8 Hz), 1.75 (1H, dd, J = 3.7, 8.6 Hz), 1.87 (1H, d, J = 14.1 Hz),
2.16 (1H, ddd, J = 1.5, 7.2, 14.2 Hz), 2.19 (1H, br s), 3.03 (1H, br s), 3.83 (1H, d, J = 12.6 Hz), 3.96 (1H,
d, J = 12.6 Hz), 4.37 (1H, d, J = 7.0 Hz), 7.40 (1H, t, J = 7.9 Hz), 7.55 (1H, d, J = 8.0 Hz), 7.91 (1H, d,
J = 7.8 Hz), 8.00 (1H, s). 13C NMR (125.8 MHz, CDCl3) δ (ppm): 15.1, 19.9, 20.0, 27.7, 32.9, 33.2, 35.2,
66.9, 73.7, 94.0, 128.3, 130.2, 132.6, 133.8, 134.3, 135.1, 166.8. Anal. calcd for C17H21ClO4: C 62.86; H 6.52.
Found: C 62.97; H 6.75.
Synthesis of (1R,2S,3S,5R)-2-hydroxymethyl-5-isopropylbicyclo[3.1.0]hexane-2,3-diol (19). To a solution of
17 or 18 (33 mg, 0.10 mmoL) in EtOH (2 mL), a 10% cold aqueous solution of NaOH (1 mL) was
added at room temperature. The reaction mixture was stirred for 30 min, then concentrated under
reduced pressure to evaporate ethanol, and the aqueous residue was extracted with CH2Cl2 (3 × 3 mL).
The combined organic extract was washed with brine, dried (Na2SO4) and evaporated.
Compound 19: 17 mg (91%); white crystalline powder; mp: 90–92 ◦C; [α]20D = +45 (c = 0.250;
MeOH). 1H NMR (500 MHz, (CD3)2SO) δ (ppm): 0.22–0.26 (1H, m), 0.80 (3H, d, J = 6.8 Hz), 0.85 (3H,
d, J = 6.8 Hz), 0.94 (1H, t, J = 3.9 Hz), 1.03 (1H, dd, J = 3.5, 8.5 Hz), 1.23 (1H, septet, J = 6.8 Hz), 1.55
(1H, d, J = 13.6 Hz), 1.89 (1H, ddd, J = 1.0, 7.1, 13.6 Hz), 3.21 (1H, dd, J = 6.4, 11.1 Hz), 3.33 (1H, dd,
J = 5.6, 11.1 Hz), 3.64–3.68 (1H, m), 3.95 (1H, s), 4.44 (1H, d, J = 3.8), 4.55 (1H, t, J = 5.9 Hz). 13C NMR
(125.8 MHz, (CD3)2SO) δ (ppm): 13.2, 19.4, 19.5, 29.2, 31.2, 32.0, 35.0, 66.8, 71.1, 80.8. Anal. calcd for
C10H18O3: C 64.49; H 9.74. Found: C 64.69; H 9.83.
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3.4. General Procedure for the Reaction of Aldehydes with Diethylzinc in the Presence of Chiral Catalyst
To the respective catalyst (0.1 mmoL), 1 M Et2Zn in n-hexane solution (3 mL, 3 mmoL) was added
under an Ar atmosphere at room temperature. The reaction was stirred for 25 min at room temperature
(see Table 1), and benzaldehyde (1 mmoL) was then added to the solution with subsequent stirring at
room temperature (see Table 1) for a further 20 h. The reaction was quenched with a saturated NH4Cl
solution (15 mL), and the mixture was extracted with EtOAc (2 × 20 mL). The combined organic phase
was washed with H2O (10 mL), dried (Na2SO4), and evaporated under vacuum. The crude secondary
alcohols obtained were purified by flash column chromatography (Rf = 0.54; n-hexane/EtOAc = 4/1).
The ee and absolute configuration of the resulting material were determined by chiral HPLC analysis on
a Chiralcel OD-H column and the data are as follows: 1-phenyl-1-propanol; V(n-hexane)/V(2-propanol)
= 95: 5, 0.7 mL/min, 215 nm, tR1 = 6.29 min for R-isomer, tR2 = 6.73 min for S-isomer [7].
3.5. X-Ray Structure Determination of 11
Single crystals of 11 were grown by warming up 11 in heptane until almost full dissolution, and
then the solution was abruptly cooled in an ice bath. X-ray intensity data were collected at –123 ◦C
on a Rigaku UltraX 18S generator (Xenocs mirrors, Mo Kα radiation, λ = 0.71073 Å) using a MAR345
image plate. The images were interpreted and integrated with CrysAlisPRO [48], and the implemented
absorption correction was applied. Using Olex2 [49], the structures were solved with the ShelXS [50]
structure solution program by Direct Methods, and refined with the ShelXL [51] refinement package
using full-matrix least-squares minimization on F2. Non-hydrogen atoms were refined anisotropically,
and hydrogen atoms in the riding mode with isotropic temperature factors fixed at 1.2 times Ueq of the
parent atoms (1.5 for the –CH3 and the –OH groups). Because compound 11 is composed of only light
atoms (C, H, O), it was not possible to determine its absolute configuration. CCDC number 1814013
contains the supplementary crystallographic data.
Crystal Data for C10H18O2 (M = 170.24 g/moL): orthorhombic, space group P212121 (no. 19),
a = 6.1474(2) Å, b = 8.1525(3) Å, c = 19.6783(6) Å, V = 986.21(6) Å3, Z = 4, T = 150.15 K,
µ(MoKα) = 0.078 mm−1, Dcalc = 1.147 g/cm3, 8206 reflections measured (10.216◦ ≤ 2θ ≤ 52.006◦),
1915 unique (Rint = 0.0310, Rsigma = 0.0189) which were used in all calculations. The final R1 was 0.0328
(I > 2σ(I)) and wR2 was 0.0848 (all data).
4. Conclusions
In conclusion, we have developed a library of new chiral sabinol-based aminodiol, diol, and
triol derivatives (6–19). Our results revealed that functionalization of (+)-sabinol occurred with high
stereoselectivity, affording only a single diastereomeric product in each case. Stereoselectivities,
however, were found to be lower as compared with other monoterpene-based trifunctional catalysts.
It is surmised that, because of the appreciable steric influence of the bicyclic ring system and the freely
rotating hydroxymethyl or aminomethyl group, a stable transition state could not be formed in the
reactions of the applied catalysts and Et2Zn. From this point of view, aminodiols have proven to be
more efficient catalysts compared to diol or triol derivatives.
On the other hand, because of the observed different reactivity of the functional groups (caused
by the steric hindrance of the bicyclic system of sabinane skeleton), the obtained aminodiols, diols,
and triols may serve as useful building blocks for the synthesis of new heterocyclic ring systems and
biologically active compounds.
Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/23/4/771/s1,
1H, 13C NMR, HSQC, HMBC, COSY, and NOESY spectra of new compounds (S3–S24) and crystal structure of
diol 11 (S25).
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